The Teleflex veteran has left the company without a permanent successor. Teleflex has made Stuart Randle, a board member, interim president and CEO, effective immediately. Stephen Klasko, the ...

In early January 2026, Teleflex announced the past departure of Chairman, President and CEO Liam Kelly, appointed long-time ...

Teleflex said the decision to move on from Kelly, who had been CEO since January 2018 and chairman since May 2022, is part of its shift to a more focused, higher-growth organization with the planned ...

Stuart Randle Appointed Interim President and CEOBoard Initiates Search for Permanent CEODr. Stephen Klasko Appointed Chairman of the ...

Teleflex shares fell after the medical technology company said it was parting ways with its chief executive officer, and cut its outlook for the year. The stock was down 13% to $110.36 in late morning ...

With this transaction, Intersurgical will integrate the Acute Care and Interventional Urology product ranges, technical expertise, and operations, enabling the Company to deliver a broader, more ...

Teleflex Incorporated (NYSE: NYSE: TFX), a global provider of medical technologies, has seen its stock price touch a 52-week low, reaching $128.33. According to InvestingPro data, the company ...

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular and peripheral vascular intervention devices WAYNE, Pa., Feb. 27, 2025 ...

Teleflex announced a major leadership transition effective January 7–8, 2026, with long-time Chairman, President and CEO Liam Kelly departing and board member Stuart Randle, a veteran medical device ...

Teleflex Earnings: Inline Earnings, Guidance Improved Due to Less Adverse Tariff Impact Teleflex reported year-on-year quarterly revenue growth of 1% on an adjusted constant currency basis and 9% ...